ARTCLINE

ARTCLINE‘s vision is to become the leading biotech company for immune cell based extracorporeal sepsis therapy... We, the founders, and the team of ARTCLINE have been successfully involved in the transfer of medical inventions from university research to industrial applications. We have an extensive network and many years of experience in the development of biopharmaceuticals and medical devices... Artcline has developed its patented ARTICE® Therapy to market readiness and regulatory approvals have been obtained already. The final clinical validation is currently being conducted in a controlled randomized multicenter study in Germany (ReActIF-ICE) to evaluate the effectiveness of ARTICE®.

Also known as: ARTCLINE GmbH

Registration numbers: HRB 10591 (W)

Primary location: Rostock Germany